Medicare Enrolled
Dr. Jambur Chandrashekar, M.D.
Nephrology · Indio, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chandrashekar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chandrashekar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chandrashekar
Dr. Jambur Chandrashekar is a nephrology specialist in Indio, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chandrashekar performed 1,862 Medicare services across 862 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chandrashekar received a total of $5,906 from 49 pharmaceutical and/or device companies across 289 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chandrashekar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 32% volume in CA
$5,906 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,862
Medicare services
Top 32% in CA for nephrology
862
Unique beneficiaries
$122
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~98 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
669 | $66 | $100 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
336 | $305 | $450 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
316 | $91 | $140 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
173 | $98 | $135 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
78 | $136 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
74 | $66 | $90 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
56 | $108 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $111 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
34 | $144 | $225 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
23 | $42 | $150 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
19 | $30 | $30 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
16 | $69 | $70 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
16 | $8 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,906
Total received (2018-2024)
Avg $844/year across 7 years
Top 16% in CA for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
289
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,731 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$175 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,094
2023
$868
2022
$645
2021
$934
2020
$823
2019
$969
2018
$573
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$191
Bayer Healthcare Pharmaceuticals Inc.
$182
Travere Therapeutics, Inc.
$121
Lilly USA, LLC
$76
Amgen Inc.
$76
Otsuka America Pharmaceutical, Inc.
$63
Fresenius USA Marketing, Inc.
$61
SHIELD THERAPEUTICS INC
$43
CALLIDITAS THERAPEUTICS US INC.
$38
Ardelyx, Inc.
$34
GlaxoSmithKline, LLC.
$31
Medtronic, Inc.
$30
Novo Nordisk Inc
$29
Xeris Pharmaceuticals, Inc.
$28
Merck Sharp & Dohme LLC
$25
PFIZER INC.
$24
ABBVIE INC.
$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Top 3 companies account for 45.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$811
AstraZeneca Pharmaceuticals LP
$728
Fresenius USA Marketing, Inc.
$707
Otsuka America Pharmaceutical, Inc.
$380
Novo Nordisk Inc
$282
PFIZER INC.
$260
Bayer Healthcare Pharmaceuticals Inc.
$230
Lilly USA, LLC
$224
Janssen Pharmaceuticals, Inc
$175
Merck Sharp & Dohme LLC
$169
Vifor Pharma, Inc.
$129
Amarin Pharma Inc.
$128
Travere Therapeutics, Inc.
$121
GlaxoSmithKline, LLC.
$116
Merck Sharp & Dohme Corporation
$100
Bayer HealthCare Pharmaceuticals Inc.
$99
Xeris Pharmaceuticals, Inc.
$73
TOPCON HEALTHCARE SOLUTIONS, INC.
$70
Phadia US Inc.
$69
Baxter Healthcare
$62
Abbott Laboratories
$60
Relypsa, Inc.
$57
AbbVie Inc.
$57
Ardelyx, Inc.
$53
Esperion Therapeutics, Inc.
$49
ABBVIE INC.
$45
Daiichi Sankyo Inc.
$43
SHIELD THERAPEUTICS INC
$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$43
Ultragenyx Pharmaceutical Inc.
$42
Novartis Pharmaceuticals Corporation
$42
Keryx Biopharmaceuticals, Inc.
$38
CALLIDITAS THERAPEUTICS US INC.
$38
Alexion Pharmaceuticals, Inc.
$37
Seqirus USA Inc
$33
SANOFI PASTEUR INC.
$32
DEXCOM, INC.
$30
Medtronic, Inc.
$30
Nevro Corp.
$26
Horizon Therapeutics plc
$22
Calliditas Therapeutics US Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Dexcom, Inc.
$18
Hologic Sales and Service, LLC
$18
Mylan Specialty L.P.
$18
Azurity Pharmaceuticals, Inc.
$17
E.R. Squibb & Sons, L.L.C.
$16
Biohaven Pharmaceuticals, Inc.
$15
SANOFI-AVENTIS U.S. LLC
$13
Top 3 companies account for 38.0% of all-time payments
Associated products mentioned in payments ›
2008T BLUESTAR HEMODIALYSIS MACHINE · ACCRUFER · APTIMA · Aimovig · Aranesp · Auryxia · BASAGLAR · BELSOMRA · BEXSERO · BREZTRI · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · DEXCOM CGM · DEXCOM G6 TRANSMITTER · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUCELVAX QUADRIVALENT · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · Fluad Quadrivalent · FreeStyle Libre 2 · GARDASIL · GVOKE HYPOPEN · GVOKE PFS · HARMONY · Horizant · IBSRELA · INJECTAFER · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LYRICA · LYUMJEV · MINIMED 780G · MOUNJARO · NEXLETOL · NURTEC ODT · Omnia · Otezla · Ozempic · PREVNAR 13 · PREVNAR 20 · Parsabiv · QULIPTA · REXULTI · RYBELSUS · Repatha · Rybelsus · SAMSCA · SHINGRIX · SOLIRIS · SYNTHROID · TARPEYO · TOUJEO · TRULICITY · Tresiba · UBRELVY · ULTOMIRIS · VERQUVO · Vascepa · Velphoro · Veltassa · Venofer · Victoza · Wegovy · XARELTO · XIFAXAN · YUPELRI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Nephrologists within 10 mi
8
Per 100K population
0.3
County median income
$89,672
Nearest hospital
JOHN F KENNEDY MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chandrashekar is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chandrashekar experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Chandrashekar performed 669 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chandrashekar receive payments from pharmaceutical companies?
Yes. Dr. Chandrashekar received a total of $5,906 from 49 companies across 289 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chandrashekar's costs compare to other nephrologists in Indio?
Dr. Chandrashekar's average Medicare payment per service is $122. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chandrashekar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Indio
Browse nephrologists in Indio ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in CA
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in CA
Which CA nephrologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Fresenius USA Marketing, Inc. Payments to Doctors
See all physicians who received payments from Fresenius USA Marketing, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology